Free digital therapy support with brite™: biosyn and XO Life support users through strategic partnership

Munich, Germany, July 1, 2025 — biosyn Arzneimittel GmbH, a pharmaceutical and biotechnology company specialized in trace elements, is announcing a strategic partnership in the area of digital therapy support together with XO Life, a leading digital health scale-up. As part of this cooperation, BIOSYN therapy areas will be available on the brite™ platform via web access or via app for iOS and Android. After free registration, users have access to well-founded, comprehensibly prepared and validated medical information around the clock. In addition, they can document their treatment processes, gain individual insights and receive expert support when needed. In addition, brite™ offers the opportunity to exchange ideas with other users — for mutual motivation and emotional support. Thanks to its versatile functions, the platform can help users take preparations reliably.

Informative, individual and available 24/7: 
Free digital therapy support

The new BIOSYN areas on the brite™ platform provide information about BIOSYN preparations, offer reminder functions and intuitive user guidance. Practical application tips, videos and the option to document the intake or use can help users carry out the therapy. Patients can also share their experiences with others and exchange ideas. The systematic recording of one's own patient experiences, so-called patient-reported experiences (PREs) or patient-reported outcomes (PROs), can also be shared with the treating physician. Digital support does not replace medical advice, but can supplement medical care with clear and easily accessible information.

Digital support for transparency and trust

The brite™ platform creates added value — by making medical content understandable and supporting users in their everyday lives. With their joint approach, biosyn and XO Life aim to promote transparency and sustainably strengthen consistent use in the course of therapy.

“Consistent and safe use cannot be taken for granted in many cases. That is why, for biosyn, high-quality products and smart, digital support go together. With the brite™ platform, we want to create exactly this connection,” says Michaela Ast, BU Head of Marketing & Sales at biosyn.

Dr. Friderike Bruchmann, Co-Founder & CEO of XO Life, adds: “Well-informed users can make their own health decisions. Our collaboration with biosyn supports understandable, everyday and reliable communication. ”

About biosyn Arzneimittel GmbH

biosyn Arzneimittel GmbH is a pharmaceutical and biotech company based in Fellbach. It specializes in trace elements, world market leader in high-dose selenium injections, and developer and operator of two globally unique GMP drug manufacturing plants. In addition, biosyn is active in the biotech sector with a glycoprotein that is isolated from Megathura crenulata, a marine snail found in California. 70 percent of sales are generated outside Germany — in 27 countries around the world.

Active in the fields of oncology, intensive care and endocrinology, biosyn and its products are a partner for clinics and registered doctors in the field of integrative medicine, and thus conventional medicine and naturopathy.

More information about the company is available at:

Site: https://biosyn.de
Instagram: https://www.instagram.com/biosyn_we.care/
Facebook: https://www.facebook.com/biosynarzneimittel
LinkedIn: https://www.linkedin.com/company/biosyn-arzneimittel-gmbh/posts/?feedView=all&viewAsMember=true

‍

About XO Life

XO Life has created a globally unique meta-platform, the brite™ platform, for digital product and therapy support for patients. During their product use or therapy, patients are accompanied with verified medical and health-related content, record their health and treatment history, receive personalized insights and medical support from experts, and can exchange ideas with other patients. 
Manufacturers can open their own product and therapy areas on the 
license the brite™ platform and with your own branding, your own content, 
Make questions and services available to their patients. Through personalized information and continuous support during therapies, manufacturers make an important contribution to treatment success, treatment adherence and application safety for patients.

XO Life is one of the biggest hopefuls in healthcare and is one of the leading digital health scaleups in Germany and Europe. 
XO Life is the market leader in Germany and works with world market leaders 
together with medium-sized German pharmaceutical companies and orphan drug manufacturers. The brite™ platform has recently been offered in all European countries and languages.

More links

Site: www.xo-life.com

LinkedIn: https://www.linkedin.com/company/xo-life

YouTube: https://www.youtube.com/@xo-life/featured

‍

Sources:

¹ Statista infographic. Available online at: https://de.statista.com/infografik/24797/umfrage-zum-konsum-von-nahrungsergaenzungsmitteln-in-deutschland/#:~:text=Etwas%20mehr%20als%2075%20Prozent,Studien%2DTeilnehmer%3Ainnen%20einnimmt. Last accessed: June 2025.

² Dietary supplements vs. drugs. Federal Office for Consumer Protection and Food Safety. Available online at: https://www.bvl.bund.de/DE/Arbeitsbereiche/01_Lebensmittel/03_Verbraucher/04_NEM/01_NEM_Arzneimittel/NEM_Arzneimittel_node.html#:~:text=Grundsätzlich%20gilt:%20Arzneimittel%20sollen%20Krankheiten,verkauft%20werden%20oder%20aufgemacht%20sein. Last accessed: June 2025.

‍

Press contact

XO Life GmbH

Lisa M. Köhler, M.D.

Head of Medical Affairs & Pharmacovigilance

Agnes-Pockels bow 1  

80992 Munich

email: pr@xo-life.com

‍

biosyn Arzneimittel GmbH

Safinaz Ölmez-Nosworthy

Schorndorferstrasse 32

70734 Fellbach

email: Safinaz_Oelmez-Nosworthy@biosyn.de